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Abstract: 
Background.  
Although pulmonary artery banding (PAB) is a common palliative procedure 
for pediatric heart malformation, there are concerns of pressure overload 
and concomitant immune reactions in the right ventricle causing post-
surgical complications such as pericardial effusion. At this time, no clear 
guidelines as to potential risk factors or procedural contraindications have 
been widely disseminated. Therefore, a study was undertaken to examine 
wide-ranging factors to find potential biomarkers for post-surgical PE 
formation risk.  
Methods.  
A retrospective study was conducted on all cardiac surgeries conducted 
over an 8-year period and the main inclusion criterion was PE development 
after PAB that required surgical drainage. 9 patients were then analyzed 
against a control group of 45 patients with respect to body measurements, 
concomitant surgeries, genetic screens, lab tests and cardiac function 
parameters.  
Results.  
Trisomy 21 was strongly associated with development of severe PE 
(requiring surgical drainage) after PAB and postoperative serum albumin 
levels in trisomy 21 patients were associated with PE development. Other 
parameters showed no significant correlation with PE development.  
Conclusions.  
Our data indicates a strong association between trisomy 21 and PE 
http://mc.manuscriptcentral.com/wjpchs
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For Peer Review
requiring drainage after PAB which is in line with translational research 
findings. Pressure overload from PAB may play a role in the formation of 
severe PE that is exacerbated by cardiac structural defects commonly 
associated with trisomy 21.  Surgical teams should therefore use caution 
and plan to implement drainage in PAB cases, and postoperative serum 
albumin may serve as a useful biomarker for PE formation.  
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Abstract 
Background. 
Although pulmonary artery banding (PAB) is a common palliative procedure for pediatric 
heart malformation, there are concerns of pressure overload and concomitant immune 
reactions in the right ventricle causing post-surgical complications such as pericardial effusion. 
At this time, no clear guidelines as to potential risk factors or procedural contraindications 
have been widely disseminated. Therefore, a study was undertaken to examine wide-ranging 
factors to find potential biomarkers for post-surgical pericardial effusion formation risk.  
Methods. 
A retrospective study was conducted on all cardiac surgeries conducted over an 8-year period 
and the main inclusion criterion was pericardial effusion development after PAB that required 
surgical drainage. 9 cases were then analyzed against a control group of 45 cases with respect 
to body measurements, concomitant surgeries, genetic screens, lab tests and cardiac function 
parameters. 
Results. 
Trisomy 21 was strongly associated with development of severe pericardial effusion  after 
PAB and postoperative serum albumin levels in trisomy 21 patients were associated with 
pericardial effusion development. Other parameters showed no significant correlation with 
pericardial effusion development.  
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Conclusions. 
Our data indicates a strong association between trisomy 21 and pericardial effusion requiring 
drainage after PAB which is in line with translational research findings. Pressure overload 
from PAB may play a role in the formation of severe pericardial effusion that is exacerbated 
by cardiac structural defects commonly associated with trisomy 21.  Surgical teams should 
therefore use caution and plan to implement drainage in PAB cases, and postoperative serum 
albumin may serve as a useful biomarker for pericardial effusion formation.   
(249words) 
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Introduction:   
Pulmonary artery banding (PAB) is a common palliative procedure for cardiac 
malformations with shunt-related pulmonary overflow, especially in low birth weight infants. 
However, animal modeling has shown that pressure overload as a consequence of PAB 
accelerates inflammation in the right ventricular myocardium which may lead to pericardial 
effusion production [1-2].  Such a result may lead to undesirable surgical outcomes if 
drainage is delayed [3-5]. As its etiology is poorly understood, postoperative pericardial 
effusion is often reported as post pericardiotomy syndrome (PPS) and the reported incidence 
varies widely [6]. As PPS describes any immune-mediated reaction to post-surgical trauma to 
the pericardium, precise PPS diagnoses are therefore difficult because of overlapping 
definitions [7-8].  A preliminary analysis of our institutional experience showed that the 
most prevalent procedure related to pericardial effusion was PAB. Therefore in this study, we 
looked exclusively into PAB cases to elucidate the predictors of postoperative pericardial 
effusion requiring drainage and tested multiple factors associated with the surgeries, including 
genomic screening, operation time and blood testing data.   
 
Materials and Methods:  
As a preliminary analysis, we reviewed all cardiac surgeries (532 cases) performed at 
the University of Tsukuba Hospital for structural congenital heart disease between April 2008 
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and July 2016.  As a need for drainage can be taken as a measure of pericardial effusion 
severity, the main inclusion criterion was pericardial effusion after PAB which required 
drainage. From a safety and reliable outcome perspective, our first choice for pericardial 
effusion after cardiac surgery is surgical drainage. In these cases, especially when the effusion 
envelops the heart in the pericardial cavity, we prefer to create a small reopening of the 
surgical site incision rather than use other interventional drainage techniques (such as 
pericardiocentesis). Nineteen cases were selected from the larger patient pool with 45 
non-drainage cases serving as control. Clinical data were reviewed retrospectively. Data 
collected for comparison included gender, age, height, weight at PAB, and trisomy 21 for 
patient characteristics. Detailed data for concomitant procedures (arch repair for coarctation 
or interruption of the aortic arch), approach (lateral thoracotomy or median sternotomy), site 
of PAB (main or bilateral pulmonary arteries), and, if main, length of the banding tape were 
collected for analysis. Operation time, amount of bleeding, and in/out water balance per body 
weight during PAB were collected as surgical data. Daily water balance (per body weight), 
urine amount, and amount of chest tube drainage were also investigated for the first through 
third postoperative days. Maximum postoperative doses of dopamine and/or epinephrine, and 
peak serum lactate levels (LAC) were collected to assess cardiac function. Minimum values 
of serum albumin (ALB) as well as maximum values of blood urea nitrogen (BUN), 
creatinine (CRE), white blood cell count (WBC), and C-reactive protein (CRP) were also 
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investigated.  
Standard descriptive statistics were used to summarize the data and are expressed as 
median with range. Group comparisons were performed using Mann-Whitney U testing since 
the data were not normally distributed. Categorical variables are expressed as frequency with 
percentage. A p value < 0.05 was taken to indicate statistical significance. Statistical analysis 
was performed using SPSS statistical software (version 22, IBM SPSS Inc., Armonk, NY). 
Informed consent was waived because of our retrospective study design and the study was 
approved by the Institutional Review Board for Ethics in Human Subject Research of the 
University of Tsukuba Hospital (Approval No. H29-84).  
 
Results: 
Postoperative pericardial effusion which required drainage occurred in 19 out of 532 
cases (3.6%) and among these, 10 pericardial effusion incidences were after PAB (10/60 cases, 
16.7%) held during the same period. Five incidents were after closures of isolated ventricular 
septal defects (5/90cases, 5.6%) with the other 4 incidents concomitant with 4 different 
procedures (repair of atrial septal defect, atrioventricular septal defect, systemic-pulmonary 
shunt for tetralogy of Fallot, and mitral valve replacement). One case with trisomy 18, one 
case with massive pleural effusion and ascites since the fetal period, and one case that had 
mediastinitis after PAB were excluded from the study. Three cases that underwent 
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cardiopulmonary bypass for concomitant procedures were also excluded. In total, we 
experienced 54 cases of PAB and all procedures were performed as the first palliative surgery 
without using cardiopulmonary bypass. Among 54 cases, 9 developed eventual moderate to 
severe amount of pericardial effusion after removing the chest tube and required surgical 
drainage. We compared the perioperative factors between these 9 cases (pericardial effusion 
group) with 45 other cases that did not develop pericardial effusion (No pericardial effusion 
group).  
The perioperative factors between 9 cases that required surgical drainage for pericardial 
effusion and 45 cases that did not develop pericardial effusion were compared. All absolute 
data for each factor are shown in Table 1-2. The most notable finding was the higher 
incidence of trisomy 21 within the pericardial effusion group, with 6 out of 9 cases in the 
pericardial effusion group and 10 out of 45 in the No pericardial effusion group (p = 0.008) 
(Table 1). Minimum values of ALB after PAB were lower in the pericardial effusion group 
compared to the No pericardial effusion group (p = 0.009) while pre-PAB baseline values did 
not differ between the groups. This difference in minimum ALB after PAB disappeared when 
we isolated values from the 38 cases without trisomy21 (Table 2). Other perioperative 
parameters did not differ between groups.  Taken together, this data indicates that genetic 
screening for trisomy 21 may be an important pre-surgical biomarker for potential 
development of pericardial effusion after PAB and that postoperative serum albumin may be a 
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useful indicator of pericardial effusion for trisomy 21 patients who must undergo PAB. Two 
out of the 16 cases with trisomy 21 had hypothyroidism before PAB and 6 cases developed 
hypothyroidism soon after PAB. Three of the cases with hypothyroidism were in the 
pericardial effusion group (3/6 cases), and the other 5 were in the No pericardial effusion 
group (5/10 cases).  
 
 Comment: 
PAB has been largely abandoned in leading cardiac centers since the advantages of 
early primary repair for congenital heart disease became clear. Nevertheless, for immature 
patients with low birth weight and serious conditions due to complex cardiac malformations, 
the relatively low invasiveness of PAB makes it a singular choice for palliative control of 
pulmonary blood flow that also prevents pulmonary vascular obstructive disease. According 
to the 2014 annual report by the Japanese Association for Thoracic and cardiovascular 
Surgery (JATS), there were 661 PAB performed mostly on newborns and infants, and within 
the “main procedure” classification, it was the most frequently selected in Japan for 
congenital heart disease even surpassing the second-place (549 cases) systemic-pulmonary 
(SP) shunt procedure [9]. 
However, frequent use may not be indicative of superior outcome. Our experience 
showed a high incidence of postoperative pericardial effusion with PAB. While no literature 
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has clearly described PAB as a risk factor of postoperative pericardial effusion, hemodynamic 
and mechanical stress changes accompanying PAB might play a key role in formation of 
postoperative pericardial effusion. Recently, the literature reports an activated inflammatory 
process in the RV myocardium after pressure overload from animal experiments [1-2]. Luite 
and colleagues suggested from their murine PAB model that pressure overload leads to right 
ventricular accumulation and increased activity of cardiac mast cells which are known as a 
component of the inflammatory response in adverse ventricular remodeling [1]. Earlier animal 
experiments also suggest that multiple molecular mechanisms (such as proteasomal changes 
and proteins like CYLD) play a synergistic role in this adverse remodeling [10].  Dewachter 
and colleagues concluded from their canine PAB model that acute afterload-induced RV 
failure from PAB is associated with increased myocardial expression of inflammatory 
cytokines and infiltration of neutrophils and macrophages [2]. Although the exact 
pathogenesis of postoperative pericardial effusion still remains unclear, underlying 
inflammation, autoimmune processes and molecular mechanisms may play a pivotal role in 
this clinical presentation [7-8].  
Interestingly, the proportion of patients with trisomy 21 was high in the pericardial 
effusion group. Since there was no difference between groups when we investigated the 
values exclusively on patients without trisomy 21, postoperative minimum ALB values 
became a trisomy-associated risk factor instead of an independent one. Therefore, we could 
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conclude that the presence of trisomy 21 is associated with increased likelihood of 
PAB-induced pericardial effusion that requires surgical drainage. Among various risk factors 
which have been reported [11-13], a recent high volume cohort study first pointed out trisomy 
21 as an independent risk factor predicting postoperative pericardial effusion [14]. In trisomy 
21 cases, more popularly known as Down syndrome (DS), pericardial effusion had often been 
reported with co-morbidties such as hypothyroidism, celiac disease, infectious disease, and 
transient abnormal myelopoiesis [15-16]. In a critical study, however, Concolino and 
colleagues showed a significant increase in the prevalence of isolated pericardial effusion in 
DS individuals apart from any associated disease or cardiac malformations [17]. From this 
finding, Elias and colleagues speculated that cardiac surgery and the resulting inflammatory 
process may provide the trigger to develop a significant postoperative pericardial effusion in 
children with DS who suffer from a greater propensity to develop pericardial effusion, in 
general [14].  
It is well known that DS, in addition to cardiac malformations with shunt-related 
pulmonary overflow, contains a higher potential for developing pulmonary vascular 
obstructive disease [18]. One of the most common shunt-related cardiac malformations 
associated with DS is the atrioventricular septal defect (AVSD) so our therapeutic strategy in 
this case is to achieve precision repair via PAB as an initial palliative in the neonate period to 
improve immediate condition and prevent the development of pulmonary vascular obstructive 
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disease.  We then perform full cardiac repair within the infancy period. Therefore, our 
experience with high pericardial effusion incidence after PAB might be due to the fact that we 
are performing PAB on DS-associated AVSD which biases outcomes to pericardial effusion 
(Figure 1).  
There are several limitations to this study, including the small number of patients 
with pericardial effusion and retrospective nature of the study. There is a potential for 
selection bias in exclusively analyzing severe cases (which may exclude true prevalence) 
since we limited the study cohort to pericardial effusion cases that required drainage. In less 
severe cases, pericardial effusion can be self-limiting or spontaneous resolution can occur 
while first-line treatments such as aspirin, non-steroidal anti-inflammatory agents, and 
corticosteroids are commonly used in less severe cases when hemodynamics are not 
threatened [12].  
In conclusion, based on our observations and those of other investigators, patients 
with DS are prone to develop pericardial effusion after PAB that requires surgical drainage. 
Postoperative serum albumin may play a role as a biomarker of pericardial effusion formation 
in DS patients and should be considered in the recovery plan as an essential lab test.   
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Table 1. Comparison of clinical characteristics and perioperative parameters in patients with or 
without pericardial effusion who underwent PAB 
           
pericardial effusion 
    No 
pericardial effusion 
   
p value           
      
(n=9) 
  
(n=45) 
                            
 
patient characteristics 
              
 
Male sex, n (%) 
   
4 (44.4%) 
  
19 (42.2%) 
  
0.90 
 
 
Age at PAB (days) 
   
24 (6-53) 
  
13 (3-147) 
  
0.60 
 
 
height at PAB (cm) 
   
48 (43.8-54.0) 
  
48.0 (36.0-61.3) 
  
0.81 
 
 
weight at PAB (g) 
   
2935 (2250-3420) 
 
2909 (1162-5495) 
 
0.08 
 
 
trisomy21, n (%) 
   
6 (66.7%) 
  
10 (22.2%) 
  
0.008 
 
  
 
  
 
 
 
 
 
   
 
 
 
   
 
 
 
 
 
 
 
cardiac diagnosis            CoA with VSD  12         
  
  
      AVSD  4     VSD  9         
      CoA with VSD  3     IAA  7         
  
      VSD  1     HLHS  7         
      Tricuspid atresia  1     AVSD  6         
  
           Single ventricle  3         
                  Truncus arteriosus 1         
operation details 
              
 
concomitant procedure of arch repair, n (%) 
 
3 (33.3%) 
  
15 (33.3%) 
  
1.00 
 
 
lateral thoracotomy approach, n (%) 
  
4 (44.4%) 
  
21 (46.7%) 
  
0.90 
 
  
(not median sternotomy) 
            
 
main PAB, n (%) 
   
9 (100%) 
  
33 (73.3%) 
  
0.08 
 
  
(not bilateral PAB) 
            
 
length of banding tape for main PAB (mm) 
 
21.0 (18.0-26.0) 
  
21.5 (19.0-23.0) 
  
0.88 
 
      
     (n=9) 
  
      (n=33) 
    
operative parameters 
              
 
operation length (mins) 
   
139 (118-226) 
  
145 (101-347) 
  
0.88 
 
 
bleeding (ml/kg) 
   
3.4 (0.0-30.4) 
  
3.0 (0.0-25.2) 
  
0.50 
 
 
In/out water balance (ml/kg) 
  
+28.9 (-15.5- +35.9) 
 
+27.6 (-28.4- +145.2) 
 
0.52 
 
                
postoperative parameters 
              
 
1st POD (ml/kg) 
             
 
In/out water balance 
   
+40.7 (-28.8- +91.5) 
 
+37.8 (-76.7- +133.6) 
 
0.60 
 
 
urine 
    
90.4 (46.1-168.0) 
 
83.2 (12.6-201.8) 
 
0.44 
 
 
drainage of chest tube 
   
3.4 (0.0-16.4) 
  
4 (0.0-26.6) 
  
0.54 
 
                
 
2nd POD (ml/kg) 
             
 
In/out water balance 
   
+0.7 (-123.3- +34.8) 
 
-0.8 (-87.9- +111.3) 
 
0.70 
 
 
urine 
    
111.3 (54.7-222.8) 
 
96.1 (5.3-203.5) 
  
0.16 
 
 
drainage of chest tube 
   
1.5 (0.0-23.9) 
  
1.5 (0.0-24.1) 
  
0.73 
 
                
 
3rd POD (ml/kg) 
             
 
In/out water balance 
   
-16.3 (-85.8- +88.4) 
 
+0.8 (-60.6- +66.9) 
 
0.77 
 
 
urine 
    
109.4 (30.3-194.2) 
 
103.9 (9.2-165.2) 
  
0.95 
 
 
drainage of chest tube 
   
0.8 (0.0-20.4) 
  
0.0 (0.0-12.4) 
  
0.41 
 
                
 
total drainage of chest tube (ml/kg) 
  
15.9 (0.0-114.8) 
  
15.0 (0.0-302.0) 
  
0.63 
 
                
 
max dopamine (γ) 
   
7 (4.0-9.0) 
  
5 (0.0-8.5) 
  
0.25 
 
 
usage of epinephrine, n (%) 
  
3 (33.3%) 
  
10 (22.2%) 
  
0.48 
 
                
 
max LAC (mmol/dl) 
   
2.0 (1.4-5.5) 
  
2.3 (0.9-8.0) 
  
0.82 
 
 
min ALB (g/dl) 
   
2.2 (1.5-2.5) 
  
2.5 (1.7-3.6) 
  
0.009 
 
 
max BUN (mg/dl) 
   
15.3 (8.6-39.1) 
  
15.6 (5.5-37.3) 
  
0.55 
 
 
max CRE (mg/dl) 
   
0.50 (0.32-0.90) 
  
0.60 (0.29-1.35) 
  
0.61 
 
 
max WBC (/µl) 
   
14700 (5500-21400) 
 
15400 (5000-23500) 
 
0.31 
 
 
max CRP (mg/dl) 
   
10.17 (4.83-12.98) 
 
9.99 (1.08-18.80) 
 
0.74 
                           
                
Results reported as median (range) or frequency (%). PAB = pulmonary artery banding; POD = post operative day; ALB = albumin;  
LAC = lactate; BUN = blood urea nitrogen; CRE = creatinine; WBC = white blood cell count; CRP = C-reactive protein.  
AVSD = atrioventricular septal defect; CoA = coarctation of the aorta; VSD = ventricular septal defect; IAA = interruption of the aortic 
arch; HLHS = hypoplastic left heart syndrome 
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Table 2. Comparison of serous ALB in patients with or without pericardial effusion who underwent 
PAB 
          
pericardial effusion 
  
No  
pericardial effusion 
p value  
    
           
pre-PAB       ALB (g/dl)  in total patients 3.0  (2.5-3.5) 3.1  (2.0-4.6) 0.78 
     
(n=9) 
 
(n=45) 
   
           
post-PAB    min ALB (g/dl)  in total patients 
 
2.2  (1.5-2.5) 2.5  (1.7-3.6) 0.009 
 
     
(n=9) 
 
(n=45) 
   
 patients without trisomy21    2.4  (2.2-2.5) 2.6  (1.7-3.6) 0.32 
     (n=3)  (n=35)    
  patients with trisomy21 2.1  (1.5-2.3) 2.4  (2.0-2.9) 0.04  
     (n=6)  (n=10)    
            
Results reported as median (range) or frequency (%). Minimum values of ALB after PAB were lower in the pericardial effusion group 
compared to the No pericardial effusion group while pre-PAB baseline values did not differ between the groups. This difference in 
minimum ALB after PAB disappeared when we isolated values from the patients without trisomy 21. PAB = pulmonary artery banding; 
ALB = albumin.  
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Figure Legends 
Figure 1.  
Schematic diagram showing the relation between the contents.   
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Abstract 
Background. 
Although pulmonary artery banding (PAB) is a common palliative procedure for pediatric 
heart malformation, there are concerns of pressure overload and concomitant immune 
reactions in the right ventricle causing post-surgical complications such as pericardial effusion. 
At this time, no clear guidelines as to potential risk factors or procedural contraindications 
have been widely disseminated. Therefore, a study was undertaken to examine wide-ranging 
factors to find potential biomarkers for post-surgical pericardial effusion formation risk.  
Methods. 
A retrospective study was conducted on all cardiac surgeries conducted over an 8-year period 
and the main inclusion criterion was pericardial effusion development after PAB that required 
surgical drainage. 9 cases were then analyzed against a control group of 45 cases with respect 
to body measurements, concomitant surgeries, genetic screens, lab tests and cardiac function 
parameters. 
Results. 
Trisomy 21 was strongly associated with development of severe pericardial effusion  after 
PAB and postoperative serum albumin levels in trisomy 21 patients were associated with 
pericardial effusion development. Other parameters showed no significant correlation with 
pericardial effusion development.  
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Conclusions. 
Our data indicates a strong association between trisomy 21 and pericardial effusion requiring 
drainage after PAB which is in line with translational research findings. Pressure overload 
from PAB may play a role in the formation of severe pericardial effusion that is exacerbated 
by cardiac structural defects commonly associated with trisomy 21.  Surgical teams should 
therefore use caution and plan to implement drainage in PAB cases, and postoperative serum 
albumin may serve as a useful biomarker for pericardial effusion formation.   
(249words) 
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Introduction:   
Pulmonary artery banding (PAB) is a common palliative procedure for cardiac 
malformations with shunt-related pulmonary overflow, especially in low birth weight infants. 
However, animal modeling has shown that pressure overload as a consequence of PAB 
accelerates inflammation in the right ventricular myocardium which may lead to pericardial 
effusion production [1-2].  Such a result may lead to undesirable surgical outcomes if 
drainage is delayed [3-5]. As its etiology is poorly understood, postoperative pericardial 
effusion is often reported as post pericardiotomy syndrome (PPS) and the reported incidence 
varies widely [6]. As PPS describes any immune-mediated reaction to post-surgical trauma to 
the pericardium, precise PPS diagnoses are therefore difficult because of overlapping 
definitions [7-8].  A preliminary analysis of our institutional experience showed that the 
most prevalent procedure related to pericardial effusion was PAB. Therefore in this study, we 
looked exclusively into PAB cases to elucidate the predictors of postoperative pericardial 
effusion requiring drainage and tested multiple factors associated with the surgeries, including 
genomic screening, operation time and blood testing data.   
 
Materials and Methods:  
As a preliminary analysis, we reviewed all cardiac surgeries (532 cases) performed at 
the University of Tsukuba Hospital for structural congenital heart disease between April 2008 
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and July 2016.  As a need for drainage can be taken as a measure of pericardial effusion 
severity, the main inclusion criterion was pericardial effusion after PAB which required 
drainage. From a safety and reliable outcome perspective, our first choice for pericardial 
effusion after cardiac surgery is surgical drainage. In these cases, especially when the effusion 
envelops the heart in the pericardial cavity, we prefer to create a small reopening of the 
surgical site incision rather than use other interventional drainage techniques (such as 
pericardiocentesis). Nineteen cases were selected from the larger patient pool with 45 
non-drainage cases serving as control. Clinical data were reviewed retrospectively. Data 
collected for comparison included gender, age, height, weight at PAB, and trisomy 21 for 
patient characteristics. Detailed data for concomitant procedures (arch repair for coarctation 
or interruption of the aortic arch), approach (lateral thoracotomy or median sternotomy), site 
of PAB (main or bilateral pulmonary arteries), and, if main, length of the banding tape were 
collected for analysis. Operation time, amount of bleeding, and in/out water balance per body 
weight during PAB were collected as surgical data. Daily water balance (per body weight), 
urine amount, and amount of chest tube drainage were also investigated for the first through 
third postoperative days. Maximum postoperative doses of dopamine and/or epinephrine, and 
peak serum lactate levels (LAC) were collected to assess cardiac function. Minimum values 
of serum albumin (ALB) as well as maximum values of blood urea nitrogen (BUN), 
creatinine (CRE), white blood cell count (WBC), and C-reactive protein (CRP) were also 
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investigated.  
Standard descriptive statistics were used to summarize the data and are expressed as 
median with range. Group comparisons were performed using Mann-Whitney U testing since 
the data were not normally distributed. Categorical variables are expressed as frequency with 
percentage. A p value < 0.05 was taken to indicate statistical significance. Statistical analysis 
was performed using SPSS statistical software (version 22, IBM SPSS Inc., Armonk, NY). 
Informed consent was waived because of our retrospective study design and the study was 
approved by the Institutional Review Board for Ethics in Human Subject Research of the 
University of Tsukuba Hospital (Approval No. H29-84).  
 
Results: 
Postoperative pericardial effusion which required drainage occurred in 19 out of 532 
cases (3.6%) and among these, 10 pericardial effusion incidences were after PAB (10/60 cases, 
16.7%) held during the same period. Five incidents were after closures of isolated ventricular 
septal defects (5/90cases, 5.6%) with the other 4 incidents concomitant with 4 different 
procedures (repair of atrial septal defect, atrioventricular septal defect, systemic-pulmonary 
shunt for tetralogy of Fallot, and mitral valve replacement). One case with trisomy 18, one 
case with massive pleural effusion and ascites since the fetal period, and one case that had 
mediastinitis after PAB were excluded from the study. Three cases that underwent 
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cardiopulmonary bypass for concomitant procedures were also excluded. In total, we 
experienced 54 cases of PAB and all procedures were performed as the first palliative surgery 
without using cardiopulmonary bypass. Among 54 cases, 9 developed eventual moderate to 
severe amount of pericardial effusion after removing the chest tube and required surgical 
drainage. We compared the perioperative factors between these 9 cases (pericardial effusion 
group) with 45 other cases that did not develop pericardial effusion (No pericardial effusion 
group).  
The perioperative factors between 9 cases that required surgical drainage for pericardial 
effusion and 45 cases that did not develop pericardial effusion were compared. All absolute 
data for each factor are shown in Table 1-2. The most notable finding was the higher 
incidence of trisomy 21 within the pericardial effusion group, with 6 out of 9 cases in the 
pericardial effusion group and 10 out of 45 in the No pericardial effusion group (p = 0.008) 
(Table 1). Minimum values of ALB after PAB were lower in the pericardial effusion group 
compared to the No pericardial effusion group (p = 0.009) while pre-PAB baseline values did 
not differ between the groups. This difference in minimum ALB after PAB disappeared when 
we isolated values from the 38 cases without trisomy21 (Table 2). Other perioperative 
parameters did not differ between groups.  Taken together, this data indicates that genetic 
screening for trisomy 21 may be an important pre-surgical biomarker for potential 
development of pericardial effusion after PAB and that postoperative serum albumin may be a 
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useful indicator of pericardial effusion for trisomy 21 patients who must undergo PAB. Two 
out of the 16 cases with trisomy 21 had hypothyroidism before PAB and 6 cases developed 
hypothyroidism soon after PAB. Three of the cases with hypothyroidism were in the 
pericardial effusion group (3/6 cases), and the other 5 were in the No pericardial effusion 
group (5/10 cases).  
 
 Comment: 
PAB has been largely abandoned in leading cardiac centers since the advantages of 
early primary repair for congenital heart disease became clear. Nevertheless, for immature 
patients with low birth weight and serious conditions due to complex cardiac malformations, 
the relatively low invasiveness of PAB makes it a singular choice for palliative control of 
pulmonary blood flow that also prevents pulmonary vascular obstructive disease. According 
to the 2014 annual report by the Japanese Association for Thoracic and cardiovascular 
Surgery (JATS), there were 661 PAB performed mostly on newborns and infants, and within 
the “main procedure” classification, it was the most frequently selected in Japan for 
congenital heart disease even surpassing the second-place (549 cases) systemic-pulmonary 
(SP) shunt procedure [9]. 
However, frequent use may not be indicative of superior outcome. Our experience 
showed a high incidence of postoperative pericardial effusion with PAB. While no literature 
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has clearly described PAB as a risk factor of postoperative pericardial effusion, hemodynamic 
and mechanical stress changes accompanying PAB might play a key role in formation of 
postoperative pericardial effusion. Recently, the literature reports an activated inflammatory 
process in the RV myocardium after pressure overload from animal experiments [1-2]. Luite 
and colleagues suggested from their murine PAB model that pressure overload leads to right 
ventricular accumulation and increased activity of cardiac mast cells which are known as a 
component of the inflammatory response in adverse ventricular remodeling [1]. Earlier animal 
experiments also suggest that multiple molecular mechanisms (such as proteasomal changes 
and proteins like CYLD) play a synergistic role in this adverse remodeling [10].  Dewachter 
and colleagues concluded from their canine PAB model that acute afterload-induced RV 
failure from PAB is associated with increased myocardial expression of inflammatory 
cytokines and infiltration of neutrophils and macrophages [2]. Although the exact 
pathogenesis of postoperative pericardial effusion still remains unclear, underlying 
inflammation, autoimmune processes and molecular mechanisms may play a pivotal role in 
this clinical presentation [7-8].  
Interestingly, the proportion of patients with trisomy 21 was high in the pericardial 
effusion group. Since there was no difference between groups when we investigated the 
values exclusively on patients without trisomy 21, postoperative minimum ALB values 
became a trisomy-associated risk factor instead of an independent one. Therefore, we could 
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conclude that the presence of trisomy 21 is associated with increased likelihood of 
PAB-induced pericardial effusion that requires surgical drainage. Among various risk factors 
which have been reported [11-13], a recent high volume cohort study first pointed out trisomy 
21 as an independent risk factor predicting postoperative pericardial effusion [14]. In trisomy 
21 cases, more popularly known as Down syndrome (DS), pericardial effusion had often been 
reported with co-morbidties such as hypothyroidism, celiac disease, infectious disease, and 
transient abnormal myelopoiesis [15-16]. In a critical study, however, Concolino and 
colleagues showed a significant increase in the prevalence of isolated pericardial effusion in 
DS individuals apart from any associated disease or cardiac malformations [17]. From this 
finding, Elias and colleagues speculated that cardiac surgery and the resulting inflammatory 
process may provide the trigger to develop a significant postoperative pericardial effusion in 
children with DS who suffer from a greater propensity to develop pericardial effusion, in 
general [14].  
It is well known that DS, in addition to cardiac malformations with shunt-related 
pulmonary overflow, contains a higher potential for developing pulmonary vascular 
obstructive disease [18]. One of the most common shunt-related cardiac malformations 
associated with DS is the atrioventricular septal defect (AVSD) so our therapeutic strategy in 
this case is to achieve precision repair via PAB as an initial palliative in the neonate period to 
improve immediate condition and prevent the development of pulmonary vascular obstructive 
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disease.  We then perform full cardiac repair within the infancy period. Therefore, our 
experience with high pericardial effusion incidence after PAB might be due to the fact that we 
are performing PAB on DS-associated AVSD which biases outcomes to pericardial effusion 
(Figure 1).  
There are several limitations to this study, including the small number of patients 
with pericardial effusion and retrospective nature of the study. There is a potential for 
selection bias in exclusively analyzing severe cases (which may exclude true prevalence) 
since we limited the study cohort to pericardial effusion cases that required drainage. In less 
severe cases, pericardial effusion can be self-limiting or spontaneous resolution can occur 
while first-line treatments such as aspirin, non-steroidal anti-inflammatory agents, and 
corticosteroids are commonly used in less severe cases when hemodynamics are not 
threatened [12].  
In conclusion, based on our observations and those of other investigators, patients 
with DS are prone to develop pericardial effusion after PAB that requires surgical drainage. 
Postoperative serum albumin may play a role as a biomarker of pericardial effusion formation 
in DS patients and should be considered in the recovery plan as an essential lab test.   
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Table 1. Comparison of clinical characteristics and perioperative parameters in patients with or 
without pericardial effusion who underwent PAB 
           
pericardial effusion 
    No 
pericardial effusion 
   
p value           
      
(n=9) 
  
(n=45) 
                            
 
patient characteristics 
              
 
Male sex, n (%) 
   
4 (44.4%) 
  
19 (42.2%) 
  
0.90 
 
 
Age at PAB (days) 
   
24 (6-53) 
  
13 (3-147) 
  
0.60 
 
 
height at PAB (cm) 
   
48 (43.8-54.0) 
  
48.0 (36.0-61.3) 
  
0.81 
 
 
weight at PAB (g) 
   
2935 (2250-3420) 
 
2909 (1162-5495) 
 
0.08 
 
 
trisomy21, n (%) 
   
6 (66.7%) 
  
10 (22.2%) 
  
0.008 
 
  
 
  
 
 
 
 
 
   
 
 
 
   
 
 
 
 
 
 
 
cardiac diagnosis            CoA with VSD  12         
  
  
      AVSD  4     VSD  9         
      CoA with VSD  3     IAA  7         
  
      VSD  1     HLHS  7         
      Tricuspid atresia  1     AVSD  6         
  
           Single ventricle  3         
                  Truncus arteriosus 1         
operation details 
              
 
concomitant procedure of arch repair, n (%) 
 
3 (33.3%) 
  
15 (33.3%) 
  
1.00 
 
 
lateral thoracotomy approach, n (%) 
  
4 (44.4%) 
  
21 (46.7%) 
  
0.90 
 
  
(not median sternotomy) 
            
 
main PAB, n (%) 
   
9 (100%) 
  
33 (73.3%) 
  
0.08 
 
  
(not bilateral PAB) 
            
 
length of banding tape for main PAB (mm) 
 
21.0 (18.0-26.0) 
  
21.5 (19.0-23.0) 
  
0.88 
 
      
     (n=9) 
  
      (n=33) 
    
operative parameters 
              
 
operation length (mins) 
   
139 (118-226) 
  
145 (101-347) 
  
0.88 
 
 
bleeding (ml/kg) 
   
3.4 (0.0-30.4) 
  
3.0 (0.0-25.2) 
  
0.50 
 
 
In/out water balance (ml/kg) 
  
+28.9 (-15.5- +35.9) 
 
+27.6 (-28.4- +145.2) 
 
0.52 
 
                
postoperative parameters 
              
 
1st POD (ml/kg) 
             
 
In/out water balance 
   
+40.7 (-28.8- +91.5) 
 
+37.8 (-76.7- +133.6) 
 
0.60 
 
 
urine 
    
90.4 (46.1-168.0) 
 
83.2 (12.6-201.8) 
 
0.44 
 
 
drainage of chest tube 
   
3.4 (0.0-16.4) 
  
4 (0.0-26.6) 
  
0.54 
 
                
 
2nd POD (ml/kg) 
             
 
In/out water balance 
   
+0.7 (-123.3- +34.8) 
 
-0.8 (-87.9- +111.3) 
 
0.70 
 
 
urine 
    
111.3 (54.7-222.8) 
 
96.1 (5.3-203.5) 
  
0.16 
 
 
drainage of chest tube 
   
1.5 (0.0-23.9) 
  
1.5 (0.0-24.1) 
  
0.73 
 
                
 
3rd POD (ml/kg) 
             
 
In/out water balance 
   
-16.3 (-85.8- +88.4) 
 
+0.8 (-60.6- +66.9) 
 
0.77 
 
 
urine 
    
109.4 (30.3-194.2) 
 
103.9 (9.2-165.2) 
  
0.95 
 
 
drainage of chest tube 
   
0.8 (0.0-20.4) 
  
0.0 (0.0-12.4) 
  
0.41 
 
                
 
total drainage of chest tube (ml/kg) 
  
15.9 (0.0-114.8) 
  
15.0 (0.0-302.0) 
  
0.63 
 
                
 
max dopamine (γ) 
   
7 (4.0-9.0) 
  
5 (0.0-8.5) 
  
0.25 
 
 
usage of epinephrine, n (%) 
  
3 (33.3%) 
  
10 (22.2%) 
  
0.48 
 
                
 
max LAC (mmol/dl) 
   
2.0 (1.4-5.5) 
  
2.3 (0.9-8.0) 
  
0.82 
 
 
min ALB (g/dl) 
   
2.2 (1.5-2.5) 
  
2.5 (1.7-3.6) 
  
0.009 
 
 
max BUN (mg/dl) 
   
15.3 (8.6-39.1) 
  
15.6 (5.5-37.3) 
  
0.55 
 
 
max CRE (mg/dl) 
   
0.50 (0.32-0.90) 
  
0.60 (0.29-1.35) 
  
0.61 
 
 
max WBC (/µl) 
   
14700 (5500-21400) 
 
15400 (5000-23500) 
 
0.31 
 
 
max CRP (mg/dl) 
   
10.17 (4.83-12.98) 
 
9.99 (1.08-18.80) 
 
0.74 
                           
                
Results reported as median (range) or frequency (%). PAB = pulmonary artery banding; POD = post operative day; ALB = albumin;  
LAC = lactate; BUN = blood urea nitrogen; CRE = creatinine; WBC = white blood cell count; CRP = C-reactive protein.  
AVSD = atrioventricular septal defect; CoA = coarctation of the aorta; VSD = ventricular septal defect; IAA = interruption of the aortic 
arch; HLHS = hypoplastic left heart syndrome 
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Table 2. Comparison of serous ALB in patients with or without pericardial effusion who underwent 
PAB 
          
pericardial effusion 
  
No  
pericardial effusion 
p value  
    
           
pre-PAB       ALB (g/dl)  in total patients 3.0  (2.5-3.5) 3.1  (2.0-4.6) 0.78 
     
(n=9) 
 
(n=45) 
   
           
post-PAB    min ALB (g/dl)  in total patients 
 
2.2  (1.5-2.5) 2.5  (1.7-3.6) 0.009 
 
     
(n=9) 
 
(n=45) 
   
 patients without trisomy21    2.4  (2.2-2.5) 2.6  (1.7-3.6) 0.32 
     (n=3)  (n=35)    
  patients with trisomy21 2.1  (1.5-2.3) 2.4  (2.0-2.9) 0.04  
     (n=6)  (n=10)    
            
Results reported as median (range) or frequency (%). Minimum values of ALB after PAB were lower in the pericardial effusion group 
compared to the No pericardial effusion group while pre-PAB baseline values did not differ between the groups. This difference in 
minimum ALB after PAB disappeared when we isolated values from the patients without trisomy 21. PAB = pulmonary artery banding; 
ALB = albumin.  
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Figure Legends 
Figure 1.  
Schematic diagram showing the relation between the contents.   
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Figure 1. Schematic diagram showing the relation between the contents.   
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